Murphy Nicole
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Murphy Nicole. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 670 | $142.54 | $95,502 | Feb 10, 2025 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 620 | $141.35 | $87,637 | Feb 7, 2025 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 117 | $214.83 | $25,135 | Apr 1, 2024 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 414 | $219.08 | $90,699 | Feb 16, 2024 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 761 | $240.98 | $183,386 | Feb 9, 2024 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 638 | $240.30 | $153,311 | Feb 8, 2024 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 116 | $278.03 | $32,251 | Mar 31, 2023 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 233 | $278.38 | $64,863 | Feb 17, 2023 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 685 | $286.30 | $196,116 | Feb 10, 2023 |
| BIIB | Head of Pharm Ops and Tech | Award / Grant | 1,340 | — | — | Jan 25, 2023 |
| BIIB | Head of Pharm Ops and Tech | Option Exercise | 131 | — | — | Dec 2, 2022 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 76 | $209.26 | $15,904 | Aug 1, 2022 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 84 | $210.65 | $17,695 | Apr 1, 2022 |
| BIIB | Head of Pharm Ops and Tech | Option Exercise | 371 | — | — | Feb 18, 2022 |
| BIIB | Head of Pharm Ops and Tech | Tax Withholding | 92 | $214.59 | $19,742 | Feb 12, 2022 |